Citations (238)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Varun Dewaker, Pratik Narain Srivastava, Saroj Verma, Ajay K. Srivastava & Yenamandra S. Prabhakar. (2022) Non-bonding energy directed designing of HDAC2 inhibitors through molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics 40:24, pages 13432-13455.
Read now
Read now
Varun Dewaker, Ajay K. Srivastava, Ashish Arora & Yenamandra S. Prabhakar. (2021) Investigation of HDAC8-ligands’ intermolecular forces through molecular dynamics simulations: profiling of non-bonding energies to design potential compounds as new anti-cancer agents. Journal of Biomolecular Structure and Dynamics 39:13, pages 4726-4751.
Read now
Read now
Sk. Abdul Amin, Nilanjan Adhikari & Tarun Jha. (2021) Development of decision trees to discriminate HDAC8 inhibitors and non-inhibitors using recursive partitioning. Journal of Biomolecular Structure and Dynamics 39:1, pages 1-8.
Read now
Read now
Ahmed A E Mourad, Mai A E Mourad & Peter G Jones. (2020) Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity. Drug Design, Development and Therapy 14, pages 3111-3130.
Read now
Read now
Suvankar Banerjee, Sk. Abdul Amin, Nilanjan Adhikari & Tarun Jha. (2020) Essential elements regulating HDAC8 inhibition: a classification based structural analysis and enzyme-inhibitor interaction study of hydroxamate based HDAC8 inhibitors. Journal of Biomolecular Structure and Dynamics 38:18, pages 5513-5525.
Read now
Read now
Yu-Guo Yuan, Qiu-Ling Peng & Sangiliyandi Gurunathan. (2017) Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer. International Journal of Nanomedicine 12, pages 6503-6520.
Read now
Read now
Yudibeth Sixto-López, Martiniano Bello, Rolando Alberto Rodríguez-Fonseca, Martha Cecilia Rosales-Hernández, Marlet Martínez-Archundia, José Antonio Gómez-Vidal & José Correa-Basurto. (2017) Searching the conformational complexity and binding properties of HDAC6 through docking and molecular dynamic simulations. Journal of Biomolecular Structure and Dynamics 35:13, pages 2794-2814.
Read now
Read now
Nguyen-Hai Nam, Tran Lan Huong, Do Thi Mai Dung, Phan Thi Phuong Dung, Dao Thi Kim Oanh, Sang Ho Park, Kyungrok Kim, Byung Woo Han, Jieun Yun, Jong Soon Kang, Youngsoo Kim & Sang-Bae Han. (2014) Synthesis, bioevaluation and docking study of 5-substitutedphenyl-1,3,4-thiadiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents. Journal of Enzyme Inhibition and Medicinal Chemistry 29:5, pages 611-618.
Read now
Read now
MarianaS. Gerova & OgnyanI. Petrov. (2014) A Convenient Synthesis of the New Histone Deacetylase Inhibitor Scriptaid. Organic Preparations and Procedures International 46:1, pages 76-79.
Read now
Read now
Akinori Sato. (2012) Vorinostat approved in Japan for treatment of cutaneous T-cell lymphomas: status and prospects. OncoTargets and Therapy 5, pages 67-76.
Read now
Read now
Nadine Martinet & Philippe Bertrand. (2011) Interpreting clinical assays for histone deacetylase inhibitors. Cancer Management and Research 3, pages 117-141.
Read now
Read now
L Rhoda Molife & Johann S de Bono. (2011) Belinostat: clinical applications in solid tumors and lymphoma. Expert Opinion on Investigational Drugs 20:12, pages 1723-1732.
Read now
Read now
Nozomu Tanji, Akira Ozawa, Tadahiko Kikugawa, Noriyoshi Miura, Toyokazu Sasaki, Kouji Azuma & Masayoshi Yokoyama. (2011) Potential of histone deacetylase inhibitors for bladder cancer treatment. Expert Review of Anticancer Therapy 11:6, pages 959-965.
Read now
Read now
Chunlei Zhang & Madeleine Duvic. (2010) Vorinostat for the treatment of cutaneous T-cell lymphoma. Expert Review of Dermatology 5:4, pages 393-401.
Read now
Read now
Faith M. Strickland & Bruce C. Richardson. (2008) Epigenetics in human autoimmunity. Autoimmunity 41:4, pages 278-286.
Read now
Read now
Madeleine Duvic & Jenny Vu. (2007) Update on the treatment of cutaneous T-cell lymphoma (CTCL): Focus on vorinostat. Biologics: Targets and Therapy 1:4, pages 377-392.
Read now
Read now
Madeleine Duvic & Jenny Vu. (2007) Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma. Expert Opinion on Investigational Drugs 16:7, pages 1111-1120.
Read now
Read now
Steve Price & Hazel J Dyke. (2007) Histone deacetylase inhibitors. Expert Opinion on Therapeutic Patents 17:7, pages 745-765.
Read now
Read now
Sabina A Antoniu. (2006) Histone deacetylase pathway: an evolving therapeutic target in chronic obstructive pulmonary disease. Expert Opinion on Therapeutic Targets 10:2, pages 329-332.
Read now
Read now
Articles from other publishers (219)
Marco Rubatto, Silvia Borriello, Nadia Sciamarrelli, Valentina Pala, Luca Tonella, Simone Ribero & Pietro Quaglino. (2023) Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies. Melanoma Research 33:6, pages 462-474.
Crossref
Crossref
Aliki Drakontaeidi & Eleni Pontiki. (2023) A Review on Molecular Docking on HDAC Isoforms: Novel Tool for Designing Selective Inhibitors. Pharmaceuticals 16:12, pages 1639.
Crossref
Crossref
Marzieh Ramezani Farani, Maryam Sarlak, Amir Gholami, Maryam Azaraian, Maryam Moradi Binabaj, Sareh Kakavandi, Murtaza M. Tambuwala, Afshin Taheriazam, Mehrdad Hashemi & Sorayya Ghasemi. (2023) Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?. Pathology - Research and Practice 248, pages 154688.
Crossref
Crossref
Seoyeon Jeong, Hwa-Ryeon Kim, June-Ha Shin, Min-Hee Son, In-Hyun Lee & Jae-Seok Roe. (2023) Streamlined DNA-encoded small molecule library screening and validation for the discovery of novel chemotypes targeting BET proteins. Molecular Therapy - Nucleic Acids 32, pages 637-649.
Crossref
Crossref
Haoling ChenZijing HuangChuxiao Chen. (2023) The Role of Histone Acetylation Modification in Dental Tissue-Derived Mesenchymal Stem Cells and Odontogenesis. Cellular Reprogramming 25:1, pages 11-19.
Crossref
Crossref
Christiana O. Appiah, Manjulata Singh, Lauren May, Ishita Bakshi, Ashish Vaidyanathan, Paul Dent, Gordon Ginder, Steven Grant, Harry Bear & Joseph Landry. 2023. Epigenetic Regulation of Cancer in Response to Chemotherapy. Epigenetic Regulation of Cancer in Response to Chemotherapy
337
385
.
Antonietta Liotti, Anne Lise Ferrara, Stefania Loffredo, Maria Rosaria Galdiero, Gilda Varricchi, Francesca Di Rella, Giorgia Teresa Maniscalco, Martina Belardo, Roberta Vastano, Rosaria Prencipe, Laura Pignata, Roberta Romano, Giuseppe Spadaro, Paola de Candia, Antonio Pezone & Veronica De Rosa. (2022) Epigenetics: An opportunity to shape innate and adaptive immune responses. Immunology 167:4, pages 451-470.
Crossref
Crossref
Shuyu Tan & Xin Li. (2022) Small‐Molecule Fluorescent Probes for Detecting HDAC Activity. Chemistry – An Asian Journal 17:22.
Crossref
Crossref
Alena B. Zuzina & Pavel M. Balaban. (2022) Contribution of histone acetylation to the serotonin-mediated long-term synaptic plasticity in terrestrial snails. Journal of Comparative Physiology A 208:5-6, pages 521-535.
Crossref
Crossref
Anne Lise Ferrara, Antonietta Liotti, Antonio Pezone & Veronica De Rosa. (2022) Therapeutic opportunities to modulate immune tolerance through the metabolism-chromatin axis. Trends in Endocrinology & Metabolism 33:7, pages 507-521.
Crossref
Crossref
Qi Ding, Xueting Wu, Xuan Li & Hongbing Wang. (2022) Vorinostat Corrects Cognitive and Non-Cognitive Symptoms in a Mouse Model of Fragile X Syndrome. International Journal of Neuropsychopharmacology 25:2, pages 147-159.
Crossref
Crossref
Ran Tang, Yiqun Li, Fang Han, Zhenzhi Li, Xiaoyu Lin, Haoxiu Sun, Xiaoqing Zhang, Qinghua Jiang, Huan Nie & Yu Li. (2022) A CTCF-Binding Element and Histone Deacetylation Cooperatively Maintain Chromatin Loops, Linking to Long-Range Gene Regulation in Cancer Genomes. Frontiers in Oncology 11.
Crossref
Crossref
Wen Li, Feifei Li, Xia Zhang, Hui-Kuan Lin & Chuan Xu. (2021) Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
K. V. Athira, Prashant Sadanandan & Sumana Chakravarty. (2021) Repurposing Vorinostat for the Treatment of Disorders Affecting Brain. NeuroMolecular Medicine 23:4, pages 449-465.
Crossref
Crossref
Tran Khac Vu, Nguyen Thi Thanh, Nguyen Van Minh, Nguyen Huong Linh, Nguyen Thi Phương Thao, Trương Thuc Bao Nguyen, Doan Thi Hien, Luu Van Chinh, Ta Hong Duc, Lai Duc Anh & Pham-The Hai. (2021) Novel Conjugated Quinazolinone-Based Hydroxamic Acids: Design, Synthesis and Biological Evaluation. Medicinal Chemistry 17:7, pages 732-749.
Crossref
Crossref
Ryan W. Logan, Angela R. Ozburn, Rachel N. Arey, Kyle D. Ketchesin, Alicia Winquist, Andrew Crain, Brian T. D. Tobe, Darius Becker-Krail, Matthew B. Jarpe, Xiangning Xue, Wei Zong, Zhiguang Huo, Puja K. Parekh, Xiyu Zhu, Ethan Fitzgerald, Hui Zhang, Jeffrey Oliver-Smith, Lauren M. DePoy, Mariah A. Hildebrand, Evan Y. Snyder, George C. Tseng & Colleen A. McClung. (2020) Valproate reverses mania-like behaviors in mice via preferential targeting of HDAC2. Molecular Psychiatry 26:8, pages 4066-4084.
Crossref
Crossref
Aliya Kh. Vinarskaya, Pavel M. Balaban, Matvey V. Roshchin & Alena B. Zuzina. (2021) Sodium butyrate as a selective cognitive enhancer for weak or impaired memory. Neurobiology of Learning and Memory 180, pages 107414.
Crossref
Crossref
Saumitra Gajjar & Bhoomika M. Patel. (2021) Common targets for a deadly duo of diabetes mellitus and colon cancer: Catching two fish with one worm. European Journal of Pharmacology 893, pages 173805.
Crossref
Crossref
Rini Varghese & Anuradha Majumdar. (2021) Current Therapies in Nephrotic Syndrome: HDAC inhibitors, an Emerging Therapy for Kidney Diseases. Current Research in Biotechnology 3, pages 182-194.
Crossref
Crossref
Zhenghui Huang, Ruoxi Li, Tongke Tang, Dazheng Ling, Manjiong Wang, Dandan Xu, Maoxin Sun, Lulu Zheng, Feng Zhu, Hui Min, Rachasak Boonhok, Yan Ding, Yuhao Wen, Yicong Chen, Xiaokang Li, Yuxi Chen, Taiping Liu, Jiping Han, Jun Miao, Qiang Fang, Yaming Cao, Yun Tang, Jie Cui, Wenyue Xu, Liwang Cui, Jin Zhu, Gary Wong, Jian Li & Lubin Jiang. (2020) A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1. Cell Discovery 6:1.
Crossref
Crossref
Verona Buocikova, Ivan Rios-Mondragon, Eleftherios Pilalis, Aristotelis Chatziioannou, Svetlana Miklikova, Michal Mego, Karlis Pajuste, Martins Rucins, Naouale El Yamani, Eleonora Marta Longhin, Arkadij Sobolev, Muriel Freixanet, Victor Puntes, Aiva Plotniece, Maria Dusinska, Mihaela Roxana Cimpan, Alena Gabelova & Bozena Smolkova. (2020) Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives. Cancers 12:12, pages 3622.
Crossref
Crossref
Somayeh Layeghi-Ghalehsoukhteh, Shreoshi Pal Choudhuri, Ozhan Ocal, Yalda Zolghadri, Victor Pashkov, Hanspeter Niederstrasser, Bruce A. Posner, Havish S. Kantheti, Ana C. Azevedo-Pouly, Huocong Huang, Luc Girard, Raymond J. MacDonald, Rolf A. Brekken & Thomas M. Wilkie. (2020) Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics. Scientific Reports 10:1.
Crossref
Crossref
Rohan Gupta, Rashmi K. Ambasta & Pravir Kumar. (2020) Identification of novel class I and class IIb histone deacetylase inhibitor for Alzheimer's disease therapeutics. Life Sciences 256, pages 117912.
Crossref
Crossref
Ekta Shirbhate, Divya, Preeti Patel, Vijay K. Patel, Ravichandran Veerasamy, Prabodh C. Sharma & Harish Rajak. (2020) Searching for Potential HDAC2 Inhibitors: Structure-activity Relationship Studies on Indole-based Hydroxamic Acids as an Anticancer Agent. Letters in Drug Design & Discovery 17:7, pages 905-917.
Crossref
Crossref
Yudibeth Sixto-López, José Antonio Gómez-Vidal, Nuria de Pedro, Martiniano Bello, Martha Cecilia Rosales-Hernández & José Correa-Basurto. (2020) Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines. Scientific Reports 10:1.
Crossref
Crossref
Dang Thi Tuyet Anh, Dinh Thi Cuc, Le Nhat Thuy Giang, Nguyen Thi Hien, Vu Ngoc Doan, Nguyen Ha Thanh, Nguyen Van Tuyen & Phan Van Kiem. (2020) Design, Synthesis, and Cytotoxic Evaluation of Novel Lupane Triterpenoid Derived Hydroxamates. Natural Product Communications 15:6, pages 1934578X2093196.
Crossref
Crossref
Jack Meng‐Fen Su, Jeffrey C. Murray, Rene Y. McNall‐Knapp, Daniel C. Bowers, Shafqat Shah, Adekunle M. Adesina, Arnold C. Paulino, Eunji Jo, Qianxing Mo, Patricia A. Baxter & Susan M. Blaney. (2020) A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high‐grade glioma. Pediatric Blood & Cancer 67:6.
Crossref
Crossref
Hajar Sirous, Giuseppe Campiani, Simone Brogi, Vincenzo Calderone & Giulia Chemi. (2020) Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors. Molecules 25:8, pages 1952.
Crossref
Crossref
Anna Wardowska. (2020) The epigenetic face of lupus: Focus on antigen-presenting cells. International Immunopharmacology 81, pages 106262.
Crossref
Crossref
Loredana Poeta, Agnese Padula, Benedetta Attianese, Mariaelena Valentino, Lucia Verrillo, Stefania Filosa, Cheryl Shoubridge, Adriano Barra, Charles E Schwartz, Jesper Christensen, Hans van Bokhoven, Kristian Helin, Maria Brigida Lioi, Patrick Collombat, Jozef Gecz, Lucia Altucci, Elia Di Schiavi & Maria Giuseppina Miano. (2019) Histone demethylase KDM5C is a SAHA-sensitive central hub at the crossroads of transcriptional axes involved in multiple neurodevelopmental disorders. Human Molecular Genetics 28:24, pages 4089-4102.
Crossref
Crossref
Nguyen V. Minh, Nguyen T. Thanh, Hoang T. Lien, Dinh T.P. Anh, Ho D. Cuong, Nguyen H. Nam, Pham T. Hai, Le Minh-Ngoc, Huong Le-Thi-Thu, Luu V. Chinh & Tran K. Vu. (2019) Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents. Anti-Cancer Agents in Medicinal Chemistry 19:12, pages 1543-1557.
Crossref
Crossref
Roberta Mazzone, Clemens Zwergel, Marco Artico, Samanta Taurone, Massimo Ralli, Antonio Greco & Antonello Mai. (2019) The emerging role of epigenetics in human autoimmune disorders. Clinical Epigenetics 11:1.
Crossref
Crossref
Hamam & Palaniyar. (2019) Post-Translational Modifications in NETosis and NETs-Mediated Diseases. Biomolecules 9:8, pages 369.
Crossref
Crossref
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, Sung-Hee Ihm, Moon Gi Choi & Seong Jin Lee. (2019) Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells. Endocrine 65:1, pages 110-120.
Crossref
Crossref
Caitlin Lynch, Jinghua Zhao, Srilatha Sakamuru, Li Zhang, Ruili Huang, Kristine Witt, B. Merrick, Christina Teng & Menghang Xia. (2019) Identification of Compounds That Inhibit Estrogen-Related Receptor Alpha Signaling Using High-Throughput Screening Assays. Molecules 24:5, pages 841.
Crossref
Crossref
Hussein Hamam, Meraj Khan & Nades Palaniyar. (2019) Histone Acetylation Promotes Neutrophil Extracellular Trap Formation. Biomolecules 9:1, pages 32.
Crossref
Crossref
Shahrzad Movafagh & Amanda Munson. 2019. Epigenetics of Cancer Prevention. Epigenetics of Cancer Prevention
75
105
.
Allyson Flower & Oussama Abla. 2019. Resistance to Targeted Therapies in Lymphomas. Resistance to Targeted Therapies in Lymphomas
87
110
.
Adriana T. Lopez, Susan Bates & Larisa Geskin. (2018) Current Status of HDAC Inhibitors in Cutaneous T-cell Lymphoma. American Journal of Clinical Dermatology 19:6, pages 805-819.
Crossref
Crossref
Devon Zimmerman, Krupa Patel, Matthew Hall & Jacob Elmer. (2018) Enhancement of transgene expression by nuclear transcription factor Y and CCCTC‐binding factor. Biotechnology Progress 34:6, pages 1581-1588.
Crossref
Crossref
Aline A Zuma & Wanderley de Souza. (2018) Histone deacetylases as targets for antitrypanosomal drugs. Future Science OA 4:8, pages FSO325.
Crossref
Crossref
Seok Kyo Seo, Jae Hoon Lee, Seung Joo Chon, Bo Hyon Yun, Sihyun Cho, Young Sik Choi & Byung Seok Lee. (2018) Trichostatin A Induces NAG-1 Expression and Apoptosis in Human Endometriotic Stromal Cells. Reproductive Sciences 25:9, pages 1349-1356.
Crossref
Crossref
S. H. Kim, J. G. Kang, C. S. Kim, S.-H. Ihm, M. G. Choi, H. J. Yoo & S. J. Lee. (2017) Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells. Journal of Endocrinological Investigation 41:6, pages 677-689.
Crossref
Crossref
Evanthia Galanis, S Keith Anderson, C Ryan Miller, Jann N Sarkaria, Kurt Jaeckle, Jan C Buckner, Keith L Ligon, Karla V Ballman, Dennis F MooreJrJr, Michael Nebozhyn, Andrey Loboda, David Schiff, Manmeet Singh Ahluwalia, Eudocia Q Lee, Elizabeth R Gerstner, Glenn J Lesser, Michael Prados, Stuart A Grossman, Jane Cerhan, Caterina Giannini & Patrick Y Wen. (2018) Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02. Neuro-Oncology 20:4, pages 546-556.
Crossref
Crossref
Kingsley Ibhazehiebo, Cezar Gavrilovici, Cristiane L de la Hoz, Shun-Chieh Ma, Renata Rehak, Gaurav Kaushik, Paola L Meza Santoscoy, Lucas Scott, Nandan Nath, Do-Young Kim, Jong M Rho & Deborah M Kurrasch. (2018) A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target. Brain 141:3, pages 744-761.
Crossref
Crossref
Ayman B. Farag, Heba A. Ewida & Mahmoud Salama Ahmed. (2018) Design, synthesis, and biological evaluation of novel amide and hydrazide based thioether analogs targeting Histone deacteylase (HDAC) enzymes. European Journal of Medicinal Chemistry 148, pages 73-85.
Crossref
Crossref
Shengdong Wang, Hengyuan Li, Chenyi Ye, Peng Lin, Binghao Li, Wei Zhang, Lingling Sun, Zhan Wang, Deting Xue, Wangsiyuan Teng, Xingzhi Zhou, Nong Lin & Zhaoming Ye. (2018) Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates. Frontiers in Immunology 9.
Crossref
Crossref
Seokmin Kim, Yuno Lee, Songmi Kim, Sang Jik Lee, Phil Kyeong Heo, Siu Kim, Yong Jung Kwon & Keun Woo Lee. (2018) Identification of Novel Human HDAC8 Inhibitors by Pharmacophore-based Virtual Screening and Density Functional Theory Approaches. Bulletin of the Korean Chemical Society 39:2, pages 197-206.
Crossref
Crossref
Suraj Peri, Andrew J. Andrews, Aarti Bhatia & Ranee Mehra. 2018. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer
327
352
.
Sk Abdul Amin, Nilanjan Adhikari & Tarun Jha. (2017) Structure–activity relationships of hydroxamate-based histone deacetylase-8 inhibitors: reality behind anticancer drug discovery. Future Medicinal Chemistry 9:18, pages 2211-2237.
Crossref
Crossref
Beatriz Álvarez-Rodríguez, Alfonso Latorre, Christian Posch & Álvaro Somoza. (2017) Recent advances in uveal melanoma treatment. Medicinal Research Reviews 37:6, pages 1350-1372.
Crossref
Crossref
Sk. Abdul Amin, Nilanjan Adhikari & Tarun Jha. (2017) Is dual inhibition of metalloenzymes HDAC-8 and MMP-2 a potential pharmacological target to combat hematological malignancies?. Pharmacological Research 122, pages 8-19.
Crossref
Crossref
Wei Lv, Guangming Zhang, Cyril Barinka, James H. Eubanks & Alan P. Kozikowski. (2017) Design and Synthesis of Mercaptoacetamides as Potent, Selective, and Brain Permeable Histone Deacetylase 6 Inhibitors. ACS Medicinal Chemistry Letters 8:5, pages 510-515.
Crossref
Crossref
Said M. Elshafae, Nicole A. Kohart, Lucas A. Altstadt, Wessel P. Dirksen & Thomas. J. Rosol. (2017) The Effect of a Histone Deacetylase Inhibitor (AR‐42) on Canine Prostate Cancer Growth and Metastasis. The Prostate 77:7, pages 776-793.
Crossref
Crossref
Mudassier Ahmad, Mushtaq A. Aga, Javeed Ahmad Bhat, Brijesh Kumar, Abdul Rouf, Neena Capalash, Mubashir Javeed Mintoo, Ashok Kumar, Priya Mahajan, Dilip Manikrao Mondhe, Amit Nargotra, Parduman Raj Sharma, Mohmmad Afzal Zargar, Ram A. Vishwakarma, Bhahwal Ali Shah, Subhash Chandra Taneja & Abid Hamid. (2017)
Exploring Derivatives of Quinazoline Alkaloid
l
-Vasicine as Cap Groups in the Design and Biological Mechanistic Evaluation of Novel Antitumor Histone Deacetylase Inhibitors
. Journal of Medicinal Chemistry 60:8, pages 3484-3497.
Crossref
Crossref
Tran-Thi-Lan Huong, Do-Thi-Mai Dung, Nguyen-Van Huan, Le-Van Cuong, Pham-The Hai, Le-Thi-Thu Huong, Jisung Kim, Yong-Guk Kim, Sang-Bae Han & Nguyen-Hai Nam. (2017) Novel N -hydroxybenzamides incorporating 2-oxoindoline with unexpected potent histone deacetylase inhibitory effects and antitumor cytotoxicity. Bioorganic Chemistry 71, pages 160-169.
Crossref
Crossref
Selvi Kunnimalaiyaan, Kevin Sokolowski, T. Clark Gamblin & Muthusamy Kunnimalaiyaan. (2017) Suberoylanilide hydroxamic Acid, a histone deacetylase inhibitor, alters multiple signaling pathways in hepatocellular carcinoma cell lines. The American Journal of Surgery 213:4, pages 645-651.
Crossref
Crossref
Mee-Young Ahn & Jung-Hoon Yoon. (2017) Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma. Oncology Reports 37:1, pages 540-546.
Crossref
Crossref
Leslie A. Garrett, Whitfield B. Growdon, Bo R. Rueda & Rosemary Foster. (2016) Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer. Journal of Ovarian Research 9:1.
Crossref
Crossref
Sarah C. Nicolson, Chengwen Li, Matthew L. Hirsch, Vincent Setola & R. Jude Samulski. (2016) Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens. Journal of Virology 90:16, pages 7019-7031.
Crossref
Crossref
Vu Thi Ha, Vu Tuan Kien, Le Huy Binh, Vu Dinh Tien, Nguyen Thi Thuy My, Nguyen Hai Nam, Michael Baltas, Hyunggu Hahn, Byung Woo Han, Do Thi Thao & Tran Khac Vu. (2016) Design, synthesis and biological evaluation of novel hydroxamic acids bearing artemisinin skeleton. Bioorganic Chemistry 66, pages 63-71.
Crossref
Crossref
Natalie FischerEmmanuel SechetRobin FriedmanAurélien AmiotIradj SobhaniGiulia NigroPhilippe J. Sansonetti & Brice Sperandio. (2016) Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge. Proceedings of the National Academy of Sciences 113:21.
Crossref
Crossref
Michael Bordonaro & Darina Lazarova Lazarova. (2016) Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells. JMIR Research Protocols 5:2, pages e66.
Crossref
Crossref
H. F. Duncan, A. J. Smith, G. J. P. Fleming & P. R. Cooper. (2016) Epigenetic modulation of dental pulp stem cells: implications for regenerative endodontics. International Endodontic Journal 49:5, pages 431-446.
Crossref
Crossref
Henry F. Duncan, Anthony J. Smith, Garry J. P. Fleming, Nicola C. Partridge, Emi Shimizu, Gary P. Moran & Paul R. Cooper. (2016) The Histone-Deacetylase-Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase-13 Activity. Journal of Cellular Physiology 231:4, pages 798-816.
Crossref
Crossref
Martina Blank, Fernanda S. Petry, Martina Lichtenfels, Fernanda E. Valiati, Arethuza S. Dornelles & Rafael Roesler. (2015) TrkB blockade in the hippocampus after training or retrieval impairs memory: protection from consolidation impairment by histone deacetylase inhibition. Journal of Neural Transmission 123:3, pages 159-165.
Crossref
Crossref
Tor Paaske Utheim, Panagiotis Salvanos, Øygunn Aass Utheim, Sten Ræder, Lara Pasovic, Ole Olstad, Maria Fideliz de la Paz & Amer Sehic. (2016) Transcriptome Analysis of Cultured Limbal Epithelial Cells on an Intact Amniotic Membrane following Hypothermic Storage in Optisol-GS. Journal of Functional Biomaterials 7:1, pages 4.
Crossref
Crossref
Daoud Meerzaman, Barbara K. Dunn, Maxwell Lee, Qingrong Chen, Chunhua Yan & Sharon Ross. (2016) The promise of omics-based approaches to cancer prevention. Seminars in Oncology 43:1, pages 36-48.
Crossref
Crossref
Tzu-Chin Wu, Yi-Chin Lin, Hsiao-Ling Chen, Pei-Ru Huang, Shang-Yu Liu & Shu-Lan Yeh. (2016) The enhancing effect of genistein on apoptosis induced by trichostatin A in lung cancer cells with wild type p53 genes is associated with upregulation of histone acetyltransferase. Toxicology and Applied Pharmacology 292, pages 94-102.
Crossref
Crossref
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, Sung-Hee Ihm, Moon Gi Choi, Hyung Joon Yoo & Seong Jin Lee. (2015) The heat shock protein 90 inhibitor SNX5422 has a synergistic activity with histone deacetylase inhibitors in induction of death of anaplastic thyroid carcinoma cells. Endocrine 51:2, pages 274-282.
Crossref
Crossref
Katherine Ververis, Selly Marzully, Chrishan S. Samuel, Tim D. Hewitson & Tom C. Karagiannis. 2016. Kidney Research. Kidney Research
279
289
.
Madeleine Duvic. (2015) Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sézary syndrome. Hematology 2015:1, pages 529-544.
Crossref
Crossref
Zhuomin Huang, Shiwen Peng, Jayne Knoff, Sung Yong Lee, Benjamin Yang, Tzyy-Choou Wu & Chien-Fu Hung. (2015) Combination of proteasome and HDAC inhibitor enhances HPV16 E7-specific CD8+ T cell immune response and antitumor effects in a preclinical cervical cancer model. Journal of Biomedical Science 22:1.
Crossref
Crossref
Young Kwang Chae, Su Yun Chung, Andrew A. Davis, Benedito A. Carneiro, Sunandana Chandra, Jason Kaplan, Aparna Kalyan & Francis J. Giles. (2015) Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling. Oncotarget 6:35, pages 37117-37134.
Crossref
Crossref
Tran Thi Lan Huong, Do Thi Mai Dung, Phan Thi Phuong Dung, Phung Thanh Huong, Tran Khac Vu, Hyunggu Hahn, Byung Woo Han, Jisung Kim, Minji Pyo, Sang-Bae Han & Nguyen-Hai Nam. (2015) Novel 2-oxoindoline-based hydroxamic acids: synthesis, cytotoxicity, and inhibition of histone deacetylation. Tetrahedron Letters 56:46, pages 6425-6429.
Crossref
Crossref
Jae-Young Lee, Mee Yeon Lee, Min Woo Ha, Tae Hyung Won, Hyun-Jong Cho, Jongheon Shin, Hyeung-geun Park & Dae-Duk Kim. (2015) Determination and validation of psammaplin A and its derivatives in rat plasma by liquid chromatography–tandem mass spectrometry and its application in pharmacokinetic study. Journal of Chromatography B 1000, pages 155-162.
Crossref
Crossref
T.A. Varghese, M.A. Jayasri & K. Suthindhiran. (2015) Marine Actinomycetes as potential source for histone deacetylase inhibitors and epigenetic modulation. Letters in Applied Microbiology 61:1, pages 69-76.
Crossref
Crossref
Tae-Gul Lee, Eun-Hui Jeong, Seo Yun Kim, Hye-Ryoun Kim & Cheol Hyeon Kim. (2015) The combination of irreversible EGFR TKIs and SAHA induces apoptosis and autophagy-mediated cell death to overcome acquired resistance in EGFRT790M-mutated lung cancer. International Journal of Cancer 136:11, pages 2717-2729.
Crossref
Crossref
Sung-Min Chun, Ji-Young Lee, Jene Choi, Je-Hwan Lee, Jung Jin Hwang, Chung-Soo Kim, Young-Ah Suh & Se Jin Jang. (2015) Epigenetic Modulation with HDAC Inhibitor CG200745 Induces Anti-Proliferation in Non-Small Cell Lung Cancer Cells. PLOS ONE 10:3, pages e0119379.
Crossref
Crossref
Michael Bordonaro. (2015) CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer. World Journal of Gastroenterology 21:27, pages 8238.
Crossref
Crossref
Shane O’Grady & Matthew W. Lawless. 2015. Epigenetic Cancer Therapy. Epigenetic Cancer Therapy
269
288
.
Bowen Yan, Xuehui Li, Alta Johnson, Yurong Yang, Wei Jian & Yi Qiu. 2015. Epigenetic Gene Expression and Regulation. Epigenetic Gene Expression and Regulation
397
423
.
Sarika Tiwari, Subramanian Dharmarajan, Mahesh Shivanna, Deborah C Otteson & Teri L Belecky-Adams. (2014) Histone deacetylase expression patterns in developing murine optic nerve. BMC Developmental Biology 14:1.
Crossref
Crossref
Simmi Sharma, Mudassier Ahmad, Javeed Ahmad Bhat, Arvind Kumar, Manjeet Kumar, Mohmmad Afzal Zargar, Abid Hamid & Bhahwal Ali Shah. (2014) Design, synthesis and biological evaluation of β-boswellic acid based HDAC inhibitors as inducers of cancer cell death. Bioorganic & Medicinal Chemistry Letters 24:19, pages 4729-4734.
Crossref
Crossref
Darren M. Hutt, Daniela Martino Roth, Hélène Vignaud, Christophe Cullin & Marion Bouchecareilh. (2014) The Histone Deacetylase Inhibitor, Vorinostat, Represses Hypoxia Inducible Factor 1 Alpha Expression through Translational Inhibition. PLoS ONE 9:8, pages e106224.
Crossref
Crossref
Angelo Paci, Gareth Veal, Christophe Bardin, Dominique Levêque, Nicolas Widmer, Jos Beijnen, Alain Astier & Etienne Chatelut. (2014) Review of therapeutic drug monitoring of anticancer drugs part 1 – Cytotoxics. European Journal of Cancer 50:12, pages 2010-2019.
Crossref
Crossref
Tuan Hiep Tran, Thiruganesh Ramasamy, Duy Hieu Truong, Beom Soo Shin, Han-Gon Choi, Chul Soon Yong & Jong Oh Kim. (2014) Development of Vorinostat-Loaded Solid Lipid Nanoparticles to Enhance Pharmacokinetics and Efficacy against Multidrug-Resistant Cancer Cells. Pharmaceutical Research 31:8, pages 1978-1988.
Crossref
Crossref
Padmaja Mummaneni & Stacy S. Shord. (2014) Epigenetics and Oncology. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:5, pages 495-505.
Crossref
Crossref
Sophia N. Ononye, Michael D. VanHeyst, Charles Giardina, Dennis L. Wright & Amy C. Anderson. (2014) Studies on the antiproliferative effects of tropolone derivatives in Jurkat T-lymphocyte cells. Bioorganic & Medicinal Chemistry 22:7, pages 2188-2193.
Crossref
Crossref
Jhanelle E. Gray, Eric Haura, Alberto Chiappori, Tawee Tanvetyanon, Charles C. Williams, Mary Pinder-Schenck, Julie A. Kish, Jenny Kreahling, Richard Lush, Anthony Neuger, Leticia Tetteh, Angela Akar, Xiuhua Zhao, Michael J. Schell, Gerold Bepler & Soner Altiok. (2014) A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors. Clinical Cancer Research 20:6, pages 1644-1655.
Crossref
Crossref
Shujuan Sun, Yingyan Han, Jia Liu, Yong Fang, Yuan Tian, Jianfeng Zhou, Ding Ma & Peng Wu. (2014) Trichostatin A Targets the Mitochondrial Respiratory Chain, Increasing Mitochondrial Reactive Oxygen Species Production to Trigger Apoptosis in Human Breast Cancer Cells. PLoS ONE 9:3, pages e91610.
Crossref
Crossref
Umberto Galderisi & Gianfranco Peluso. 2014. Tumor Dormancy, Quiescence, and Senescence, Volume 2. Tumor Dormancy, Quiescence, and Senescence, Volume 2
143
153
.
Francesca Paino, Marcella Noce, Virginia Tirino, Pasqualina Naddeo, Vincenzo Desiderio, Giuseppe Pirozzi, Alfredo Rosa, Luigi Laino, Lucia Altucci & Gianpaolo Papaccio. (2014) Histone Deacetylase Inhibition with Valproic Acid Downregulates Osteocalcin Gene Expression in Human Dental Pulp Stem Cells and Osteoblasts: Evidence for HDAC2 Involvement. Stem Cells 32:1, pages 279-289.
Crossref
Crossref
Yu-Ming Lee, Yeh-Fon Lin & Carmay Lim. (2014) Factors Controlling the Role of Zn and Reactivity of Zn-bound Cysteines in Proteins: Application to Drug Target Discovery. Journal of the Chinese Chemical Society 61:1, pages 142-150.
Crossref
Crossref
Ding Wang, Caiyun Fang, Nobel C. Zong, David A. Liem, Martin Cadeiras, Sarah B. Scruggs, Hongxiu Yu, Allen K. Kim, Pengyuan Yang, Mario Deng, Haojie Lu & Peipei Ping. (2013) Regulation of Acetylation Restores Proteolytic Function of Diseased Myocardium in Mouse and Human. Molecular & Cellular Proteomics 12:12, pages 3793-3802.
Crossref
Crossref
Nguyen-Hai Nam, Tran Lan Huong, Do Thi Mai Dung, Phan Thi Phuong Dung, Dao Thi Kim Oanh, Do Quyen, Le Thi Thao, Sang Ho Park, Kyung Rok Kim, Byung Woo Han, Jieun Yun, Jong Soon Kang, Youngsoo Kim & Sang-Bae Han. (2013) Novel isatin-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents. European Journal of Medicinal Chemistry 70, pages 477-486.
Crossref
Crossref
Joshua A. Day & Seth M. Cohen. (2013) Investigating the Selectivity of Metalloenzyme Inhibitors. Journal of Medicinal Chemistry 56:20, pages 7997-8007.
Crossref
Crossref
Sung Yong Lee, Zhuomin Huang, Tae Heung Kang, Ruey-Shyang Soong, Jayne Knoff, Ellen Axenfeld, Chenguang Wang, Ronald D. Alvarez, Ching-Shih Chen, Chien-Fu Hung & T.-C. Wu. (2013) Histone deacetylase inhibitor AR-42 enhances E7-specific CD8+ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination. Journal of Molecular Medicine 91:10, pages 1221-1231.
Crossref
Crossref
ZHONG-HUA LI, XIAO-BING ZHANG, XI-QIAN HAN, CONG-RAN FENG, FENG-SHAN WANG, PENG GEORGE WANG, JIE SHEN & YI-KANG SHI. (2013) Antitumor effects of a novel histone deacetylase inhibitor NK-HDAC-1 on breast cancer. Oncology Reports 30:1, pages 499-505.
Crossref
Crossref
Ruethairat Sriraksa & Temduang Limpaiboon. (2013) Histone Deacetylases and their Inhibitors as Potential Therapeutic Drugs for cholangiocarcinoma - Cell Line findings. Asian Pacific Journal of Cancer Prevention 14:4, pages 2503-2508.
Crossref
Crossref
Helle Jensen, Michael Hagemann-Jensen, Felicia Lauridsen & Søren Skov. (2013) Regulation of NKG2D-ligand cell surface expression by intracellular calcium after HDAC-inhibitor treatment. Molecular Immunology 53:3, pages 255-264.
Crossref
Crossref
Chiranjeevi Sandi, Sahar Al-Mahdawi & Mark A. Pook. (2013) Epigenetics in Friedreich's Ataxia: Challenges and Opportunities for Therapy. Genetics Research International 2013, pages 1-12.
Crossref
Crossref
Seo-Hee You, Hee-Woong Lim, Zheng Sun, Molly Broache, Kyoung-Jae Won & Mitchell A Lazar. (2013) Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo. Nature Structural & Molecular Biology 20:2, pages 182-187.
Crossref
Crossref
You Me Sung, Taehee Lee, Hyejin Yoon, Amanda Marie DiBattista, Jung Min Song, Yoojin Sohn, Emily Isabella Moffat, R. Scott Turner, Mira Jung, Jungsu Kim & Hyang-Sook Hoe. (2013) Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease. Experimental Neurology 239, pages 192-201.
Crossref
Crossref
Nancy H. Nabilsi, Carolina E. Pardo, Maria Zajac-Kaye & Michael P. Kladde. 2013. Cell and Molecular Biology of Breast Cancer. Cell and Molecular Biology of Breast Cancer
211
259
.
Madeleine Duvic. 2013. Lymphoma. Lymphoma
287
329
.
Lv Li, Hong-Juan Dai, Mao Ye, Shu-Ling Wang, Xiao-Juan Xiao, Jie Zheng, Hui-Yong Chen, Yu-hao Luo & Jing Liu. (2012) Lycorine induces cell-cycle arrest in the G0/G1 phase in K562 cells via HDAC inhibition. Cancer Cell International 12:1.
Crossref
Crossref
Renee E Stubbins, Aisha Hakeem & Nomelí P Núñez. (2012) Using components of the vitamin D pathway to prevent and treat colon cancer. Nutrition Reviews 70:12, pages 721-729.
Crossref
Crossref
Marion Bouchecareilh, Darren M. Hutt, Patricia Szajner, Terence R. Flotte & William E. Balch. (2012) Histone Deacetylase Inhibitor (HDACi) Suberoylanilide Hydroxamic Acid (SAHA)-mediated Correction of α1-Antitrypsin Deficiency. Journal of Biological Chemistry 287:45, pages 38265-38278.
Crossref
Crossref
Jie Lv, Changsheng Du, Wei Wei, Zhiying Wu, Guixian Zhao, Zhenxin Li & Xin Xie. (2012) The Antiepileptic Drug Valproic Acid Restores T Cell Homeostasis and Ameliorates Pathogenesis of Experimental Autoimmune Encephalomyelitis. Journal of Biological Chemistry 287:34, pages 28656-28665.
Crossref
Crossref
Laura Gatti, Valentina Benedetti, Michelandrea De Cesare, Elisabetta Corna, Raffaella Cincinelli, Nadia Zaffaroni, Franco Zunino & Paola Perego. (2012) Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells. Journal of Inorganic Biochemistry 113, pages 94-101.
Crossref
Crossref
Jasmine Zain. (2012) Role of Histone Deacetylase Inhibitors in the Treatment of Lymphomas and Multiple Myeloma. Hematology/Oncology Clinics of North America 26:3, pages 671-704.
Crossref
Crossref
Alexander Dewerth, Timo Wonner, Justus Lieber, Verena Ellerkamp, Steven W. Warmann, Jörg Fuchs & Sorin Armeanu-Ebinger. (2012) In vitro evaluation of the Aurora kinase inhibitor VX-680 for Hepatoblastoma. Pediatric Surgery International 28:6, pages 579-589.
Crossref
Crossref
Sophia N Ononye, Michael van Heyst, Eric M Falcone, Amy C Anderson & Dennis L Wright. (2012) Toward isozyme-selective inhibitors of histone deacetylase as therapeutic agents for the treatment of cancer. Pharmaceutical Patent Analyst 1:2, pages 207-221.
Crossref
Crossref
Andriy Marusyk, Vanessa Almendro & Kornelia Polyak. (2012) Intra-tumour heterogeneity: a looking glass for cancer?. Nature Reviews Cancer 12:5, pages 323-334.
Crossref
Crossref
Jingli Hou, Zhonghua Li, Qinghong Fang, Congran Feng, Hanwen Zhang, Weikang Guo, Huihui Wang, Guoxian Gu, Yinping Tian, Pi Liu, Ruihua Liu, Jianping Lin, Yi-kang Shi, Zheng Yin, Jie Shen & Peng George Wang. (2012)
Discovery and Extensive
in Vitro
Evaluations of NK-HDAC-1: A Chiral Histone Deacetylase Inhibitor as a Promising Lead
. Journal of Medicinal Chemistry 55:7, pages 3066-3075.
Crossref
Crossref
Dawei Huang, Xiaohui Li, Lei Sun, Zhilong Xiu & Norikazu Nishino. (2012) Synthesis, evaluation and molecular modeling of cyclic tetrapeptide histone deacetylase inhibitors as anticancer agents. Journal of Peptide Science 18:4, pages 242-251.
Crossref
Crossref
Bing Wang, Xiaolei Zhu, YunTai Kim, Jie Li, Siyuan Huang, Sofiyan Saleem, Rung-chi Li, Yun Xu, Sylvain Dore & Wangsen Cao. (2012) Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radical Biology and Medicine 52:5, pages 928-936.
Crossref
Crossref
Kazuyasu Fujii, Norihiro Suzuki, Kazuko Ikeda, Toshihisa Hamada, Takenobu Yamamoto, Tadashi Kondo & Keiji Iwatsuki. (2012) Proteomic study identified HSP 70kDa protein 1A as a possible therapeutic target, in combination with histone deacetylase inhibitors, for lymphoid neoplasms. Journal of Proteomics 75:4, pages 1401-1410.
Crossref
Crossref
Thomas Force & Ming Hui Chen. 2012. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine
1893
1903
.
Raimana Ho, Andreas Nievergelt, Claudia Simoes Pires & Muriel Cuendet. 2012. Bioactive Natural Products. Bioactive Natural Products
247
267
.
Yongqing Li & Hasan B. Alam. 2012. Recent Advances on Model Hosts. Recent Advances on Model Hosts
107
133
.
Eleni Pontiki & Dimitra Hadjipavlou-Litina. (2012) Histone deacetylase inhibitors (HDACIs). Structure-activity relationships: history and new QSAR perspectives. Medicinal Research Reviews 32:1, pages 1-165.
Crossref
Crossref
Sundarapandian Thangapandian, Shalini John, Yuno Lee, Songmi Kim & Keun Woo Lee. (2011) Dynamic Structure-Based Pharmacophore Model Development: A New and Effective Addition in the Histone Deacetylase 8 (HDAC8) Inhibitor Discovery. International Journal of Molecular Sciences 12:12, pages 9440-9462.
Crossref
Crossref
Wayne Bidlack & Raymond RodriguezSharon Ross. 2011. Nutritional Genomics. Nutritional Genomics
3
24
.
M. L. Bush, J. Oblinger, V. Brendel, G. Santarelli, J. Huang, E. M. Akhmametyeva, S. S. Burns, J. Wheeler, J. Davis, C. W. Yates, A. R. Chaudhury, S. Kulp, C.-S. Chen, L.-S. Chang, D. B. Welling & A. Jacob. (2011) AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas. Neuro-Oncology 13:9, pages 983-999.
Crossref
Crossref
Yakun Wan, Weiming Chen, Jie Xing, Jinyin Tan, Bing Li, Huiying Chen, Zhanxian Lin, Jung-Hsien Chiang & Saleem Ramsey. (2011) Transcriptome profiling reveals a novel role for trichostatin A in antagonizing histone chaperone Chz1 mediated telomere anti‐silencing. FEBS Letters 585:15, pages 2519-2525.
Crossref
Crossref
M. M. Singh, C. A. Manton, K. P. Bhat, W.-W. Tsai, K. Aldape, M. C. Barton & J. Chandra. (2011) Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors. Neuro-Oncology 13:8, pages 894-903.
Crossref
Crossref
Andrew B. Munkacsi, Fannie W. Chen, Matthew A. Brinkman, Katsumi Higaki, Giselle Domínguez Gutiérrez, Jagruti Chaudhari, Jacob V. Layer, Amy Tong, Martin Bard, Charles Boone, Yiannis A. Ioannou & Stephen L. Sturley. (2011) An “Exacerbate-reverse” Strategy in Yeast Identifies Histone Deacetylase Inhibition as a Correction for Cholesterol and Sphingolipid Transport Defects in Human Niemann-Pick Type C Disease. Journal of Biological Chemistry 286:27, pages 23842-23851.
Crossref
Crossref
Brian M. Zeglis, NagaVaraKishore Pillarsetty, Vadim Divilov, Ronald A. Blasberg & Jason S. Lewis. (2011) The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), A PET radiotracer designed for the delineation of histone deacetylase expression in cancer. Nuclear Medicine and Biology 38:5, pages 683-696.
Crossref
Crossref
Ana-Maria Marino, Anastasios Sofiadis, Ninib Baryawno, John Inge Johnsen, Catharina Larsson, Vladana Vukojević & Tomas J. Ekström. (2011) Enhanced effects by 4-phenylbutyrate in combination with RTK inhibitors on proliferation in brain tumor cell models. Biochemical and Biophysical Research Communications 411:1, pages 208-212.
Crossref
Crossref
José García, Gianluigi Franci, Raquel Pereira, Rosaria Benedetti, Angela Nebbioso, Fátima Rodríguez-Barrios, Hinrich Gronemeyer, Lucia Altucci & Angel R. de Lera. (2011) Epigenetic profiling of the antitumor natural product psammaplin A and its analogues. Bioorganic & Medicinal Chemistry 19:12, pages 3637-3649.
Crossref
Crossref
Rainer Glauben & Britta Siegmund. (2011) Inhibition of Histone Deacetylases in Inflammatory Bowel Diseases. Molecular Medicine 17:5-6, pages 426-433.
Crossref
Crossref
Guoyi Li, Huiyi Jiang, Ming Chang, Hongrong Xie & Linsen Hu. (2011) HDAC6 α-tubulin deacetylase: A potential therapeutic target in neurodegenerative diseases. Journal of the Neurological Sciences 304:1-2, pages 1-8.
Crossref
Crossref
Jack M. Su, Xiao-Nan Li, Patrick Thompson, Ching-Nan Ou, Ashish M. Ingle, Heidi Russell, Ching C. Lau, Peter C. Adamson & Susan M. Blaney. (2011) Phase 1 Study of Valproic Acid in Pediatric Patients with Refractory Solid or CNS Tumors: A Children's Oncology Group Report. Clinical Cancer Research 17:3, pages 589-597.
Crossref
Crossref
Anat Biran, Michael Brownstein, Ronit Haklai & Yoel Kloog. (2010) Downregulation of survivin and aurora A by histone deacetylase and RAS inhibitors: A new drug combination for cancer therapy. International Journal of Cancer 128:3, pages 691-701.
Crossref
Crossref
Hoin KANG & Sangho ROH. (2011) Extended Exposure to Trichostatin A after Activation Alters the Expression of Genes Important for Early Development in Nuclear Transfer Murine Embryos. Journal of Veterinary Medical Science 73:5, pages 623-631.
Crossref
Crossref
Yongqing Li & Hasan B. Alam. (2011) Modulation of Acetylation: Creating a Pro-survival and Anti-Inflammatory Phenotype in Lethal Hemorrhagic and Septic Shock. Journal of Biomedicine and Biotechnology 2011, pages 1-15.
Crossref
Crossref
Mario Federico & Luigi Bagella. (2011) Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors. Journal of Biomedicine and Biotechnology 2011, pages 1-12.
Crossref
Crossref
Shuyang Chen & Nianli Sang. (2011) Histone Deacetylase Inhibitors: The Epigenetic Therapeutics That Repress Hypoxia-Inducible Factors. Journal of Biomedicine and Biotechnology 2011, pages 1-14.
Crossref
Crossref
Cindy Davis & Sharon Ross. 2010. Nutrition, Epigenetic Mechanisms, and Human Disease. Nutrition, Epigenetic Mechanisms, and Human Disease
77
108
.
Jiahuai Tan, Shundong Cang, Yuehua Ma, Richard L Petrillo & Delong Liu. (2010) Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. Journal of Hematology & Oncology 3:1.
Crossref
Crossref
André Fischer, Farahnaz Sananbenesi, Alison Mungenast & Li-Huei Tsai. (2010) Targeting the correct HDAC(s) to treat cognitive disorders. Trends in Pharmacological Sciences 31:12, pages 605-617.
Crossref
Crossref
Nabil HajjiBertrand Joseph. (2010) Epigenetic regulation of cell life and death decisions and deregulation in cancer. Essays in Biochemistry 48, pages 121-146.
Crossref
Crossref
Paola Conti, Lucia Tamborini, Andrea Pinto, Laura Sola, Roberta Ettari, Ciro Mercurio & Carlo De Micheli. (2010) Design and synthesis of novel isoxazole-based HDAC inhibitors. European Journal of Medicinal Chemistry 45:9, pages 4331-4338.
Crossref
Crossref
Nighat Noureen, Hamid Rashid & Saima Kalsoom. (2010) Identification of type-specific anticancer histone deacetylase inhibitors: road to success. Cancer Chemotherapy and Pharmacology 66:4, pages 625-633.
Crossref
Crossref
Ciro Mercurio, Saverio Minucci & Pier Giuseppe Pelicci. (2010) Histone deacetylases and epigenetic therapies of hematological malignancies. Pharmacological Research 62:1, pages 18-34.
Crossref
Crossref
U Lassen, L R Molife, M Sorensen, S-A Engelholm, L Vidal, R Sinha, R T Penson, P Buhl-Jensen, E Crowley, J Tjornelund, P Knoblauch & J S de Bono. (2010) A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours. British Journal of Cancer 103:1, pages 12-17.
Crossref
Crossref
Martin Kaiser, Britta Lamottke, Maren Mieth, Michael R. Jensen, Cornelia Quadt, Carlos Garcia-Echeverria, Peter Atadja, Ulrike Heider, Ivana von Metzler, Seval Türkmen & Orhan Sezer. (2010) Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma. European Journal of Haematology 84:4, pages 337-344.
Crossref
Crossref
Akira Ozawa, Nozomu Tanji, Tadahiko Kikugawa, Toyokazu Sasaki, Yutaka Yanagihara, Noriyoshi Miura & Masayoshi Yokoyama. (2010) Inhibition of bladder tumour growth by histone deacetylase inhibitor. BJU International 105:8, pages 1181-1186.
Crossref
Crossref
Jaromir Sykora & Franz-Josef Meyer-Almes. (2010)
Mechanism of Binding of the Inhibitor (
E
)-3-(Furan-2-yl)-
N
-hydroxyacrylamide to a Histone Deacetylase-like Amidohydrolase
. Biochemistry 49:7, pages 1418-1424.
Crossref
Crossref
Sharmila A Bapat. (2010) Modulation of gene expression in ovarian cancer by active and repressive histone marks. Epigenomics 2:1, pages 39-51.
Crossref
Crossref
Luca Paoluzzi, Luigi Scotto, Enrica Marchi, Jasmine Zain, Venkatraman E. Seshan & Owen A. O'Connor. (2010) Romidepsin and Belinostat Synergize the Antineoplastic Effect of Bortezomib in Mantle Cell Lymphoma. Clinical Cancer Research 16:2, pages 554-565.
Crossref
Crossref
Eva van RooijJens FielitzLillian B. SutherlandVictor L. ThijssenHarry J. CrijnsMichael J. DimaioJohn SheltonLeon J. De WindtJoseph A. HillEric N. Olson. (2010) Myocyte Enhancer Factor 2 and Class II Histone Deacetylases Control a Gender-Specific Pathway of Cardioprotection Mediated by the Estrogen Receptor. Circulation Research 106:1, pages 155-165.
Crossref
Crossref
Darren M Hutt, David Herman, Ana P C Rodrigues, Sabrina Noel, Joseph M Pilewski, Jeanne Matteson, Ben Hoch, Wendy Kellner, Jeffery W Kelly, Andre Schmidt, Philip J Thomas, Yoshihiro Matsumura, William R Skach, Martina Gentzsch, John R Riordan, Eric J Sorscher, Tsukasa Okiyoneda, John R YatesIIIIII, Gergely L Lukacs, Raymond A Frizzell, Gerard Manning, Joel M Gottesfeld & William E Balch. (2009) Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nature Chemical Biology 6:1, pages 25-33.
Crossref
Crossref
Vishal Patil, William Guerrant, Po C. Chen, Berkley Gryder, Derek B. Benicewicz, Shabana I. Khan, Babu L. Tekwani & Adegboyega K. Oyelere. (2010) Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group. Bioorganic & Medicinal Chemistry 18:1, pages 415-425.
Crossref
Crossref
Samson Mani & Zdenko Herceg. 2010. Epigenetics and Cancer, Part A. Epigenetics and Cancer, Part A
327
340
.
Edward Seto & Xiang-Jiao Yang. 2010. Handbook of Cell Signaling. Handbook of Cell Signaling
2379
2388
.
Petr Hanák. (2009) New generation of anti-cancer medicines. Kontakt 10:2, pages 442-448.
Crossref
Crossref
Samedy OukMei-Ling LiouHsiou-Chi Liou. (2009) Direct Rel/NF-κB inhibitors: structural basis for mechanism of action. Future Medicinal Chemistry 1:9, pages 1683-1707.
Crossref
Crossref
Shundong Cang, Yuehua Ma & Delong Liu. (2009) New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer. Journal of Hematology & Oncology 2:1.
Crossref
Crossref
De-Maw Chuang, Yan Leng, Zoya Marinova, Hyeon-Ju Kim & Chi-Tso Chiu. (2009) Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends in Neurosciences 32:11, pages 591-601.
Crossref
Crossref
Moo Rim Kang, Jong Soon Kang, Sang-Bae Han, Jang Hyun Kim, Dong-Myung Kim, Kiho Lee, Chang Woo Lee, Ki Hoon Lee, Chul Ho Lee, Gyoonhee Han, Jong Seong Kang, Hwan Mook Kim & Song-Kyu Park. (2009) A novel δ-lactam-based histone deacetylase inhibitor, KBH-A42, induces cell cycle arrest and apoptosis in colon cancer cells. Biochemical Pharmacology 78:5, pages 486-494.
Crossref
Crossref
MARIKA HORIUCHI, AKIO MORINOBU, TAKAAKI CHIN, YOSHITADA SAKAI, MASAHIRO KUROSAKA & SHUNICHI KUMAGAI. (2009) Expression and Function of Histone Deacetylases in Rheumatoid Arthritis Synovial Fibroblasts. The Journal of Rheumatology 36:8, pages 1580-1589.
Crossref
Crossref
Christina Restall, Judy Doherty, Hong Bin Liu, Rosemary Genovese, Lisa Paiman, Keith A. Byron, Robin L. Anderson & Anthony E. Dear. (2009) A novel histone deacetylase inhibitor augments tamoxifen-mediated attenuation of breast carcinoma growth. International Journal of Cancer 125:2, pages 483-487.
Crossref
Crossref
Alan P. Kozikowski, Yihua Chen, Tapadar Subhasish, Nancy E. Lewin, Peter M. Blumberg, Zhenyu Zhong, Melissa A. D'Annibale, Weng-Long Wang, Yong Shen & Brett Langley. (2009) Searching for Disease Modifiers-PKC Activation and HDAC Inhibition-A Dual Drug Approach to Alzheimer's Disease that Decreases Aβ Production while Blocking Oxidative Stress. ChemMedChem 4:7, pages 1095-1105.
Crossref
Crossref
Nina Saban & Maro Bujak. (2009) Hydroxyurea and hydroxamic acid derivatives as antitumor drugs. Cancer Chemotherapy and Pharmacology 64:2, pages 213-221.
Crossref
Crossref
Yufeng Chen, Rong He, Yihua Chen, Melissa A. D'Annibale, Brett Langley & Alan P. Kozikowski. (2009) Studies of Benzamide- and Thiol-Based Histone Deacetylase Inhibitors in Models of Oxidative-Stress-Induced Neuronal Death: Identification of Some HDAC3-Selective Inhibitors. ChemMedChem 4:5, pages 842-852.
Crossref
Crossref
S. Agbor-Enoh, C. Seudieu, E. Davidson, A. Dritschilo & M. Jung. (2009)
Novel Inhibitor of
Plasmodium
Histone Deacetylase That Cures
P. berghei-
Infected Mice
. Antimicrobial Agents and Chemotherapy 53:5, pages 1727-1734.
Crossref
Crossref
Joya Chandra. (2009) Oxidative Stress by Targeted Agents Promotes Cytotoxicity in Hematologic Malignancies. Antioxidants & Redox Signaling 11:5, pages 1123-1137.
Crossref
Crossref
Jason D Graci, Joseph M Colacino, Stuart W Peltz, Joseph P Dougherty & Zhengxian Gu. (2009) HIV Type-1 Latency: Targeted Induction of Proviral Reservoirs. Antiviral Chemistry and Chemotherapy 19:5, pages 177-187.
Crossref
Crossref
N. Sriwilaijaroen, S. Boonma, P. Attasart, J. Pothikasikorn, S. Panyim & W. Noonpakdee. (2009) Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA directed against malaria histone deacetylase. Biochemical and Biophysical Research Communications 381:2, pages 144-147.
Crossref
Crossref
Takashi Kumagai, Tadayuki Akagi, Julian C. Desmond, Norihiko Kawamata, Sigal Gery, Yasufumi Imai, Jee Hoon Song, Dorina Gui, Jonathan Said & H. Phillip Koeffler. (2009) Epigenetic regulation and molecular characterization of C/EBPα in pancreatic cancer cells. International Journal of Cancer 124:4, pages 827-833.
Crossref
Crossref
Wei Zhang, Michael Peyton, Yang Xie, Junichi Soh, John D. Minna, Adi F. Gazdar & Eugene P. Frenkel. (2009) Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines. Journal of Thoracic Oncology 4:2, pages 161-166.
Crossref
Crossref
Matthew D. BowmanJason R. SchminkCynthia M. McGowanChad M. KormosNicholas E. Leadbeater. (2008) Scale-Up of Microwave-Promoted Reactions to the Multigram Level Using a Sealed-Vessel Microwave Apparatus. Organic Process Research & Development 12:6, pages 1078-1088.
Crossref
Crossref
Geoffrey S. Dow, Yufeng Chen, Katherine T. Andrews, Diana Caridha, Lucia Gerena, Montip Gettayacamin, Jacob Johnson, Qigui Li, Victor Melendez, Nicanor ObaldiaIIIIII, Thanh N. Tran & Alan P. Kozikowski. (2008) Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase Inhibitors. Antimicrobial Agents and Chemotherapy 52:10, pages 3467-3477.
Crossref
Crossref
Yujun George Zheng, Jiang Wu, Ziyue Chen & Masha Goodman. (2008) Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy. Medicinal Research Reviews 28:5, pages 645-687.
Crossref
Crossref
Zhong ChenBin YanCarter Van Waes. (2008) Role of the NF-κB transcriptome and proteome as biomarkers in human head and neck squamous cell carcinomas. Biomarkers in Medicine 2:4, pages 409-426.
Crossref
Crossref
Olaia Martínez-Iglesias, Lidia Ruiz-Llorente, Ruth Sánchez-Martínez, Laura García, Alberto Zambrano & Ana Aranda. (2008) Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer. Clinical and Translational Oncology 10:7, pages 395-398.
Crossref
Crossref
Weidong Ji, Linqing Yang, Lei Yu, Jianhui Yuan, Dalin Hu, Wenjuan Zhang, Jianping Yang, Yaqin Pang, Wenxue Li, Jiachun Lu, Juan Fu, Jiakun Chen, Zhongning Lin, Wen Chen & Zhixiong Zhuang. (2008) Epigenetic silencing of O6 -methylguanine DNA methyltransferase gene in NiS-transformed cells. Carcinogenesis 29:6, pages 1267-1275.
Crossref
Crossref
Yufeng Chen, Miriam Lopez-Sanchez, Doris N. Savoy, Daniel D. Billadeau, Geoffrey S. Dow & Alan P. Kozikowski. (2008)
A Series of Potent and Selective, Triazolylphenyl-Based Histone Deacetylases Inhibitors with Activity against Pancreatic Cancer Cells and
Plasmodium falciparum
. Journal of Medicinal Chemistry 51:12, pages 3437-3448.
Crossref
Crossref
Displaying 200 of 238 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list